Seer Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Seer han disminuido a una tasa media anual de -32.4%, mientras que en la industria Life Sciences los beneficios crecieron en un 16.4% anualmente. Los ingresos han ido creciendo a una tasa media de 56.9% al año.

Información clave

-32.4%

Tasa de crecimiento de los beneficios

10.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Life Sciences	21.5%
Tasa de crecimiento de los ingresos	56.9%
Rentabilidad financiera	-21.7%
Margen neto	-517.8%
Próxima actualización de resultados	08 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

We're Keeping An Eye On Seer's (NASDAQ:SEER) Cash Burn Rate

Apr 27

Seer, Inc. (NASDAQ:SEER) Just Reported, And Analysts Assigned A US$7.00 Price Target

Mar 02

Newsflash: Seer, Inc. (NASDAQ:SEER) Analysts Have Been Trimming Their Revenue Forecasts

Nov 17

We're Not Very Worried About Seer's (NASDAQ:SEER) Cash Burn Rate

May 19

Companies Like Seer (NASDAQ:SEER) Are In A Position To Invest In Growth

Feb 06

Analysts Have Lowered Expectations For Seer, Inc. (NASDAQ:SEER) After Its Latest Results

Nov 11

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Seer. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqGS:SEER Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Dec 23	17	-86	59	53
30 Sep 23	17	-91	60	54
30 Jun 23	17	-94	61	53
31 Mar 23	16	-93	59	50
31 Dec 22	15	-93	59	46
30 Sep 22	14	-90	57	41
30 Jun 22	12	-85	53	38
31 Mar 22	10	-78	50	34
31 Dec 21	7	-71	46	29
30 Sep 21	4	-64	41	26
30 Jun 21	2	-54	32	23
31 Mar 21	1	-44	24	25
31 Dec 20	1	-33	15	19
30 Sep 20	0	-25	9	14
31 Dec 19	0	-16	5	0

Ingresos de calidad: SEER actualmente no es rentable.

Margen de beneficios creciente: SEER actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: SEER no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 32.4% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de SEER en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: SEER no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Life Sciences (-6.6%).

Rentabilidad financiera

Alta ROE: SEER tiene una rentabilidad financiera negativa (-21.74%), ya que actualmente no es rentable.

Seer Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Seer, Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Seer, Inc. to Report Q4, 2023 Results on Feb 29, 2024

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Seer, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Seer, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Recent updates

Seer, Inc., Annual General Meeting, Jun 12, 2024

We're Keeping An Eye On Seer's (NASDAQ:SEER) Cash Burn Rate

Seer, Inc. to Report Q1, 2024 Results on May 08, 2024

Founder recently sold US$107k worth of stock

New minor risk - Shareholder dilution

Seer, Inc. (NASDAQ:SEER) Just Reported, And Analysts Assigned A US$7.00 Price Target

Full year 2023 earnings: EPS exceeds analyst expectations

New minor risk - Shareholder dilution

Seer, Inc. Provides Revenue Guidance for the Full Year 2024

Seer, Inc. to Report Q4, 2023 Results on Feb 29, 2024

Seer, Inc. Announces Board and Committee Changes

Seer, Inc. Announces Management Changes

Newsflash: Seer, Inc. (NASDAQ:SEER) Analysts Have Been Trimming Their Revenue Forecasts

New minor risk - Market cap size

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Seer, Inc. Provides Revenue Guidance for the Year 2023

Seer, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Founder recently bought US$98k worth of stock

Consensus revenue estimates decrease by 29%, EPS upgraded

Seer, Inc. Revises Revenue Guidance for the Full Year 2023

Less than half of directors are independent

New major risk - Revenue and earnings growth

Price target decreased by 25% to US$6.67

Seer, Inc. Announces the Resignation of Mostafa Ronaghi as Member of the Company's Board of Directors

Seer, Inc. to Report Q2, 2023 Results on Aug 08, 2023

We're Not Very Worried About Seer's (NASDAQ:SEER) Cash Burn Rate

First quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Seer, Inc. Provides Earnings Guidance for the Year 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Founder recently sold US$57k worth of stock

Seer, Inc. to Report Q4, 2022 Results on Mar 02, 2023

Companies Like Seer (NASDAQ:SEER) Are In A Position To Invest In Growth

Executive VP recently sold US$124k worth of stock

Price target decreased to US$10.00

Analysts Have Lowered Expectations For Seer, Inc. (NASDAQ:SEER) After Its Latest Results

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Seer, Inc. Provides Revenue Guidance for the Full Year 2022

Seer, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Seer (NASDAQ:SEER) Is In A Good Position To Deliver On Growth Plans

Omead Ostadan Resigns as President of Seer, Inc. and from Its Board of Directors

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Seer, Inc. Provides Earnings Guidance for the Full Year of 2022

Seer stock tumbles aftermarket despite in-line Q2 earnings

Seer, Inc. Launches First-Of-Its-Kind Proteogenomics Workflow to Link Genetic Changes with Protein Variants with Proteograph™ Analysis Suite 2.0

Seer, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Seer, Inc.(NasdaqGS:SEER) dropped from Russell 2000 Growth Index

General Counsel & Secretary recently sold US$73k worth of stock

Companies Like Seer (NASDAQ:SEER) Are In A Position To Invest In Growth

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Seer, Inc. Provides Revenue Guidance for the Full Year 2022

Part Time President recently sold US$530k worth of stock

Part Time President recently sold US$530k worth of stock

Seer, Inc. to Report Q1, 2022 Results on May 04, 2022

Consensus forecasts updated

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Seer, Inc. Provides Earnings Guidance for the Full Year 2022

Seer, Inc. Announces Returning of its President and Chief Operating Officer, Omead Ostadan from Previously Announced 3 Month Leave of Absence

Executive VP & Chief Financial Officer recently sold US$51k worth of stock

Seer, Inc. to Report Q4, 2021 Results on Feb 28, 2022

We Think Seer (NASDAQ:SEER) Can Afford To Drive Business Growth

Seer Announces Broad Commercial Release of the Proteograph™ Product Suite

Price target decreased to US$48.67

Consensus forecasts updated

President notifies of intention to sell stock

Executive VP & Chief Financial Officer exercised options to buy US$699k worth of stock.

Executive VP & Chief Financial Officer recently sold US$532k worth of stock

President exercised options and sold US$556k worth of stock

Less than half of directors are independent

Third quarter 2021 earnings released: US$0.30 loss per share (vs US$0.79 loss in 3Q 2020)

Desglose de ingresos y gastos
Beta